Evidence map›Paper›PMID 36015080›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Therapeutic Potentials of Secoiridoids from the Fruits of

Sang Won Yeon, Su Ryeon Choi, Qing Liu, Yang Hee Jo, Da Hee Choi, Mi Ran Kim, Se Hwan Ryu, Solip Lee, Bang Yeon Hwang, Hyung Seo Hwang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sang Won YeonCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.
Su Ryeon ChoiSchool of Cosmetic Science and Beauty Biotechnology, Semyung University, Jecheon 27136, Korea.
Qing LiuFood and Pharmacy College, Xuchang University, Xuchang 461000, China.
Yang Hee JoCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.
Da Hee ChoiSchool of Cosmetic Science and Beauty Biotechnology, Semyung University, Jecheon 27136, Korea.
Mi Ran KimSchool of Cosmetic Science and Beauty Biotechnology, Semyung University, Jecheon 27136, Korea.
Se Hwan RyuCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.
Solip LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.
Bang Yeon HwangCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.
Hyung Seo HwangSchool of Cosmetic Science and Beauty Biotechnology, Semyung University, Jecheon 27136, Korea.
Mi Kyeong LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.ORCID 0000-0001-5814-2720
Chungbuk National University · KRSemyung University · KRXuchang University · CN

Funding

National Research Foundation of Korea Medical Research Center program (2017R1A5A2015541)National Research Foundation of Korea Regional Innovation Strategy (RIS)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-inflammationiridoidLigustrum lucidumpsoriasis modelsecoligulene

Identifiers

PMID36015080
PMCPMC9415915
OpenAlexW4288905265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.